|
1
|
Center MM and Jemal A: International
trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers
Prev. 20:2362–2368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mosher CE, Johnson C, Dickler M, Norton L,
Massie MJ and DuHamel K: Living with metastatic breast cancer: A
qualitative analysis of physical, psychological, and social
sequelae. Breast J. 19:285–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tanioka H, Omagari K, Kato Y, Nakata K,
Kusumoto Y, Mori I, Furukawa R, Tajima H, Koga M, Yano M, et al:
Present status of hepatitis virus-associated hepatocellular
carcinoma in Nagasaki Prefecture, Japan: A cross-sectional study of
1019 patients. J Infect Chemother. 8:64–69. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim MJ, Lee M, Choi JY and Park YN:
Imaging features of small hepatocellular carcinomas with
microvascular invasion on gadoxetic acid-enhanced MR imaging. Eur J
Radiol. 81:2507–2512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karageorgos SA, Stratakou S, Koulentaki M,
Voumvouraki A, Mantaka A, Samonakis D, Notas G and Kouroumalis EA:
Long-term change in incidence and risk factors of cirrhosis and
hepatocellular carcinoma in Crete, Greece: A 25-year study. Ann
Gastroenterol. 30:357–363. 2017.PubMed/NCBI
|
|
6
|
Davila JA, Morgan RO, Shaib Y, McGlynn KA
and El-Serag HB: Hepatitis C infection and the increasing incidence
of hepatocellular carcinoma: A population-based study.
Gastroenterology. 127:1372–1380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA,
Feldstein AF and Zein NN: The incidence and risk factors of
hepatocellular carcinoma in patients with nonalcoholic
steatohepatitis. Hepatology. 51:1972–1978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sersté T, Barrau V, Ozenne V, Vullierme
MP, Bedossa P, Farges O, Valla DC, Vilgrain V, Paradis V and Degos
F: Accuracy and disagreement of computed tomography and magnetic
resonance imaging for the diagnosis of small hepatocellular
carcinoma and dysplastic nodules: Role of biopsy. Hepatology.
55:800–806. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sano K, Ichikawa T, Motosugi U, Sou H,
Muhi AM, Matsuda M, Nakano M, Sakamoto M, Nakazawa T, Asakawa M, et
al: Imaging study of early hepatocellular carcinoma: Usefulness of
gadoxetic acid-enhanced MR imaging. Radiology. 261:834–844. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW,
Han JK and Choi BI: Small (≤1-cm) hepatocellular carcinoma:
Diagnostic performance and imaging features at gadoxetic
acid-enhanced MR imaging. Radiology. 271:748–760. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sheng RF, Zeng MS, Ji Y, Yang L, Chen CZ
and Rao SX: MR features of small hepatocellular carcinoma in
normal, fibrotic, and cirrhotic livers: A comparative study. Abdom
Imaging. 40:3062–3069. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kojiro M: Focus on dysplastic nodules and
early hepatocellular carcinoma: An Eastern point of view. Liver
Transpl. 10 Suppl 1:S3–S8. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kojiro M and Roskams T: Early
hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis.
25:133–142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao H, Zhou KR and Yan FH: Role of
multiphase scans by multirow-detector helical CT in detecting small
hepatocellular carcinoma. World J Gastroenterol. 9:2198–2201. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dale AM and Sereno MI: Improved
localizadon of cortical activity by combining EEG and MEG with MRI
cortical surface reconstruction: A linear approach. J Cogn
Neurosci. 5:162–176. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haimerl M, Wächtler M, Platzek I,
Müller-Wille R, Niessen C, Hoffstetter P, Schreyer AG,
Stroszczynski C and Wiggermann P: Added value of
Gd-EOB-DTPA-enhanced hepatobiliary phase MR imaging in evaluation
of focal solid hepatic lesions. BMC Med Imaging. 13:412013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao W, Li W, Yi X, Pei Y and Liu H, Zhang
L and Liu H: Diagnostic value of liver imaging reporting and data
system MRI on primary hepatocellular carcinoma. Zhong Nan Da Xue
Xue Bao Yi Xue Ban. 41:380–387. 2016.(In Chinese). PubMed/NCBI
|
|
18
|
Palmucci S, Mauro LA, Messina M, Russo B,
Failla G, Milone P, Berretta M and Ettorre GC: Diffusion-weighted
MRI in a liver protocol: Its role in focal lesion detection. World
J Radiol. 4:302–310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Böttcher J, Hansch A, Pfeil A, Schmidt P,
Malich A, Schneeweiss A, Maurer MH, Streitparth F, Teichgräber UK
and Renz DM: Detection and classification of different liver
lesions: Comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic
spiral CT in a clinical single centre investigation. Eur J Radiol.
82:1860–1869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Inoue T, Hyodo T, Murakami T, Takayama Y,
Nishie A, Higaki A, Korenaga K, Sakamoto A, Osaki Y, Aikata H, et
al: Hypovascular hepatic nodules showing hypointense on the
hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a
hypervascular hepatocellular carcinoma: A nationwide retrospective
study on their natural course and risk factors. Dig Dis.
31:472–479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Macdonald GA and Peduto AJ: Magnetic
resonance imaging (MRI) and diseases of the liver and biliary
tract. Part 1. Basic principles, MRI in the assessment of diffuse
and focal hepatic disease. J Gastroenterol Hepatol. 15:980–991.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hwang J, Kim SH, Lee MW and Lee JY: Small
(≤2 cm) hepatocellular carcinoma in patients with chronic liver
disease: Comparison of gadoxetic acid-enhanced 3.0 T MRI and
multiphasic 64-multirow detector CT. Br J Radiol. 85:e314–e322.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park VY, Choi JY, Chung YE, Kim H, Park
MS, Lim JS, Kim KW and Kim MJ: Dynamic enhancement pattern of HCC
smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI:
Comparison with multiphasic MDCT. Liver Int. 34:1593–1602. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McNally ME, Martinez A, Khabiri H, Guy G,
Michaels AJ, Hanje J, Kirkpatrick R, Bloomston M and Schmidt CR:
Inflammatory markers are associated with outcome in patients with
unresectable hepatocellular carcinoma undergoing transarterial
chemoembolization. Ann Surg Oncol. 20:923–928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu DH, Fei ZL, Zhou JP, Hu ZT and Hao WS:
A comparison between three-dimensional conformal radiotherapy
combined with interventional treatment and interventional treatment
alone for hepatocellular carcinoma with portal vein tumour
thrombosis. J Med Imaging Radiat Oncol. 59:109–114. 2015.
View Article : Google Scholar : PubMed/NCBI
|
